Daniel J. Brennan Boston Scientific Corp (BSX) insider trading activity

Daniel J. Brennan is EVP and CFO of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 223,921 shares of BSX, which is worth approximately $17.1 Million. The most recent transaction as insider was on May 23, 2024, when has been sold 47,621 shares (Common Stock) at a price of $75.11 per share, resulting in proceeds of $3,576,813. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 224K

17.54% 3M change

0.9% 12M change

Total Value Held $17.1 Million

Daniel J. Brennan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2024	SELL Open market or private sale	$3,576,813 $75.11 p/Share	47,621 Reduced 17.54%	223,921 Common Stock
May 22 2024	SELL Open market or private sale	$4,892,703 $75.91 p/Share	64,454 Reduced 19.18%	271,542 Common Stock
May 22 2024	BUY Exercise of conversion of derivative security	$1,372,870 $21.3 p/Share	64,454 Added 16.1%	335,996 Common Stock
Feb 20 2024	SELL Open market or private sale	$899,779 $65.86 p/Share	13,662 Reduced 4.79%	271,542 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	$178,698 $13.08 p/Share	13,662 Added 4.57%	285,204 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$108,208 $65.82 p/Share	1,644 Reduced 0.6%	271,542 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	3,706 Added 1.34%	273,186 Common Stock

Feb 17 2024	SELL Payment of exercise price or tax liability	$133,812 $65.82 p/Share	2,033 Reduced 0.75%	269,480 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	4,583 Added 1.66%	271,513 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$123,873 $65.82 p/Share	1,882 Reduced 0.7%	266,930 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	4,243 Added 1.55%	268,812 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$127,613 $65.95 p/Share	1,935 Reduced 0.73%	264,569 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	4,362 Added 1.61%	266,504 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	-	16,262 Reduced 5.84%	262,142 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	36,666 Added 11.64%	278,404 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$473,984 $57.81 p/Share	8,199 Reduced 3.28%	241,738 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	23,979 Added 8.75%	249,937 Common Stock
Mar 02 2023	SELL Open market or private sale	$1,399,800 $46.66 p/Share	30,000 Reduced 11.72%	225,958 Common Stock
Mar 01 2023	SELL Open market or private sale	$3,526,450 $46.64 p/Share	75,610 Reduced 22.8%	255,958 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	$709,235 $15.55 p/Share	45,610 Added 12.09%	331,568 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$75,077 $46.23 p/Share	1,624 Reduced 0.56%	285,958 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	3,661 Added 1.26%	287,582 Common Stock
Feb 18 2023	SELL Payment of exercise price or tax liability	$76,511 $46.54 p/Share	1,644 Reduced 0.58%	283,921 Common Stock
Feb 18 2023	BUY Exercise of conversion of derivative security	-	3,706 Added 1.28%	285,565 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$94,615 $46.54 p/Share	2,033 Reduced 0.72%	281,859 Common Stock

Also insider at

NUAN

Nuance Communications, Inc. Technology

Director

WAT

WATERS CORP Healthcare

Director

DJB

Daniel J. Brennan

EVP and CFO

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account